newsfilter
← Latest News
GlobeNewswire·

Processa Pharmaceuticals' Dr. David Young to Present at World Orphan Drug Congress USA 2025

HANOVER, Md., April 15, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer